# Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine

> **NCT04088461** · PHASE4 · COMPLETED · sponsor: **Universidad de Guanajuato** · enrollment: 31 (actual)

## Conditions studied

- Prediabetic State
- Impaired Glucose Tolerance
- Insulin Resistance

## Interventions

- **DRUG:** Linagliptin / Metformin Oral Tablet
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04088461
- **Lead sponsor:** Universidad de Guanajuato
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088461, "Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04088461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*